Eyeworld

JUL 2012

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/76185

Contents of this Issue

Navigation

Page 11 of 67

12 EW NEWS & OPINION 1,300 continued from page 11 July 2012 program chair for the ASCRS Annual Meeting. "Chicago was our biggest and best meeting ever," Dr. Steinert said. "But with so much going on, it was difficult to see it all. The MediaCenter lets you revisit what you found most interesting along with everything that you missed. And if you were unable to join us in Chicago, the MediaCenter is your portal to over 100 hours of quality educational programming. It's the entire meeting at your fingertips." Visit www.ascrs.org for addi- tional information or to access the MediaCenter. Anyone who visits the MediaCenter can also see free high- lights from the 2012 ASCRS•ASOA Symposium & Congress: Access the MediaCenter by visiting the ASCRS homepage at www.ascrs.org Film Festival Grand Prize Winner Infinite Possibility: Using Small Aperture Corneal Inlay to Treat a Variety of Presbyopic Patients Minoru Tomita, M.D., Satoshi Yukawa, M.D. Best Paper of Session Winner Evaluating the Effect of Setting Phaco Parameters Based on Imaging Cataract Density on Efficiency of Microincision Cataract Surgery Donald R. Nixon, M.D. ASCRS Glaucoma Day Obstbaum Lecture The Time Has Come the Walrus Said … To Cure Glaucoma Robert Stegmann, M.D. Cornea Day Lecture Great Debates in Refractive Surgery: This House Contends That the Phakic IOL Approach is Superior to Excimer Laser Surgery for Myopic Astigmatism After PK Sonia H. Yoo, M.D., José L. Güell, M.D. ASOA Session Preparing for ICD-10, Ann Rose EW Contact information Sebrell: csebrell@ASCRS.org The VISUAL Clinical Trials for Uveitis Clinical Trial Recruitment for Patients Diagnosed with Non-Infectious Intermediate, Posterior, or Pan-Uveitis Seeking Adult Patients for Clinical Trial Enrollment Right now, our US investigators are seeking patient referrals. Your patients may qualify if they: s !RE P TREATING G OTHER IMMUN E MEDIATEDDISEASE S PP s s AT LEAS T YE RSA OLD s(AVEBEENDIAGNOS ED OR PA N UVEITIS !RETAKINGPREDNISON E BOTH EYES s -EET OTHERINCLUSIO N Seeking New Investigators 7E 6)35!, For more information on referring a patient or becoming an investigator, visit www.visualclinicaltrials.com or call 1-800-931-6190. ARE LOOKING FOR #LINICAL 4RIALS WITH NO N INFECTIOUSINTERMEDIAT E POSTERIO R (AVE"EST#ORRECTED6ISUAL!CUIT Y "# IN AND EXCLUSION CRITERIA OR EQUIVALENTCORTICOSTEROI #66 ! OF A MI N D IMUM O F LETTERS 53 OPHTHALMOLOGISTS TO BECOMEINVESTIGATORS FOR THE Scan the code for more information © 2012 Clinical Trial Marketing Communications

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - JUL 2012